Hydralazine hydrochloride

็›้…ธ่‚ผๅฑˆๅ—ช

Report date: 2026/03/16 20:01:47
NME

Base Information

Drug NameHydralazine hydrochloride
Drug Alias Name่‚ผ่‹ฏๅ“’ๅ—ช้™็›้…ธ็›Hydralazinum็›้…ธ่‚ผ้…žๅ—ชHidralazina็›้…ธ่‚ผ่‹ฏๅ“’ๅ—ช +[8]ย 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAmine oxidase, copper containing inhibitors
TargetsAmine oxidase, copper containing
Therapy Area/IndicationsSolid tumoursHypertensionHeart Failure +[8]ย 
Global Approved IndicationsHypertensionHeart Failure
Approved Indications in ChinaHypertensionHeart Failure
Original Approved Country/TerritoryN/A
Original Approved Date1952/01/01
Country/TerritoryUnited StatesMexicoIran +[4]ย 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active IndicationsHypertensionHeart Failure
Inactive IndicationsSolid tumoursPolycystic Kidney DiseasesAlzheimer Disease +[6]ย 

Other Information

ATC CodeC02DB02